Platinum versus immunotherapy for early resectable non-small cell lung cancer: A protocol for systematic review and meta analysis

BACKGROUND: Lung cancer is one of the most common malignant tumors. Non-small cell Lung cancer (NSCLC) accounts for about 85% of the total lung cancer. For patients with resectable early NSCLC, conventional postoperative adjuvant therapy can significantly prolong the overall survival of patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Zhangwei, Luo, Fei, Yang, Xiaojie, Kang, Mingqiang, Lin, Jiangbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581118/
https://www.ncbi.nlm.nih.gov/pubmed/33120735
http://dx.doi.org/10.1097/MD.0000000000022349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581118/
https://www.ncbi.nlm.nih.gov/pubmed/33120735
http://dx.doi.org/10.1097/MD.0000000000022349

Ejemplares similares